Free 25-hydroxyvitamin D

Impact of vitamin D binding protein assays on racial-genotypic associations

Osteoporotic Fractures in Men (MrOS) Research Group

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Context: Total 25-hydroxyvitamin D (25OHD) is a marker of vitamin D status and is lower in African Americans than in whites. Whether this difference holds for free 25OHOD (f25OHD) is unclear, considering reported genetic-racial differences in vitaminDbinding protein (DBP) used to calculate f25OHD. Objectives: Our objective was to assess racial-geographic differences in f25OHD and to understand inconsistencies in racial associations with DBP and calculated f25OHD. Design: This study used a cross-sectional design. Setting: The general community in the United States, United Kingdom, and The Gambia were included in this study. Participants: Men in Osteoporotic Fractures in Men and Medical Research Council studies (N = 1057) were included. Exposures: Total 25OHD concentration, race, and DBP (GC) genotype exposures were included. Outcome Measures: Directly measured f25OHD, DBP assessed by proteomics, monoclonal and polyclonal immunoassays, and calculated f25OHD were the outcome measures. Results: Total 25OHD correlated strongly with directly measured f25OHD (Spearman r = 0.84). Measured by monoclonal assay, mean DBP in African-ancestry subjects was approximately 50% lower than in whites, whereas DBP measured by polyclonal DBP antibodies or proteomic methods was not lower in African-ancestry. Calculated f25OHD (using polyclonal DBP assays) correlated strongly with directly measured f25OHD (r = 0.80-0.83). Free 25OHD, measured or calculated from polyclonal DBP assays, reflected total 25OHD concentration irrespective of race and was lower in African Americans than in US whites. Conclusions: Previously reported racial differences in DBP concentration are likely from monoclonal assay bias, as there was no racial difference in DBP concentration by other methods. This confirms the poor vitamin D status of many African-Americans and the utility of total 25OHD in assessing vitamin D in the general population.

Original languageEnglish (US)
Pages (from-to)2226-2234
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Vitamin D-Binding Protein
Vitamin D
African Americans
Assays
Proteomics
Outcome Assessment (Health Care)
Gambia
Osteoporotic Fractures
Immunoassay
Biomedical Research
Genotype
Antibodies
Population
25-hydroxyvitamin D
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Free 25-hydroxyvitamin D : Impact of vitamin D binding protein assays on racial-genotypic associations. / Osteoporotic Fractures in Men (MrOS) Research Group.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 5, 01.05.2016, p. 2226-2234.

Research output: Contribution to journalArticle

Osteoporotic Fractures in Men (MrOS) Research Group. / Free 25-hydroxyvitamin D : Impact of vitamin D binding protein assays on racial-genotypic associations. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 5. pp. 2226-2234.
@article{8b5dc0077843436a8a108f3b68d99314,
title = "Free 25-hydroxyvitamin D: Impact of vitamin D binding protein assays on racial-genotypic associations",
abstract = "Context: Total 25-hydroxyvitamin D (25OHD) is a marker of vitamin D status and is lower in African Americans than in whites. Whether this difference holds for free 25OHOD (f25OHD) is unclear, considering reported genetic-racial differences in vitaminDbinding protein (DBP) used to calculate f25OHD. Objectives: Our objective was to assess racial-geographic differences in f25OHD and to understand inconsistencies in racial associations with DBP and calculated f25OHD. Design: This study used a cross-sectional design. Setting: The general community in the United States, United Kingdom, and The Gambia were included in this study. Participants: Men in Osteoporotic Fractures in Men and Medical Research Council studies (N = 1057) were included. Exposures: Total 25OHD concentration, race, and DBP (GC) genotype exposures were included. Outcome Measures: Directly measured f25OHD, DBP assessed by proteomics, monoclonal and polyclonal immunoassays, and calculated f25OHD were the outcome measures. Results: Total 25OHD correlated strongly with directly measured f25OHD (Spearman r = 0.84). Measured by monoclonal assay, mean DBP in African-ancestry subjects was approximately 50{\%} lower than in whites, whereas DBP measured by polyclonal DBP antibodies or proteomic methods was not lower in African-ancestry. Calculated f25OHD (using polyclonal DBP assays) correlated strongly with directly measured f25OHD (r = 0.80-0.83). Free 25OHD, measured or calculated from polyclonal DBP assays, reflected total 25OHD concentration irrespective of race and was lower in African Americans than in US whites. Conclusions: Previously reported racial differences in DBP concentration are likely from monoclonal assay bias, as there was no racial difference in DBP concentration by other methods. This confirms the poor vitamin D status of many African-Americans and the utility of total 25OHD in assessing vitamin D in the general population.",
author = "{Osteoporotic Fractures in Men (MrOS) Research Group} and Carrie Nielson and Jones, {Kerry S.} and Chun, {Rene F.} and Jacobs, {Jon M.} and Ying Wang and Martin Hewison and Adams, {John S.} and Swanson, {Christine M.} and Christine Lee and Dirk Vanderschueren and Steven Pauwels and Ann Prentice and Smith, {Richard D.} and Tujin Shi and Yuqian Gao and Schepmoes, {Athena A.} and Zmuda, {Joseph M.} and Jodi Lapidus and Cauley, {Jane A.} and Roger Bouillon and Inez Schoenmakers and Eric Orwoll",
year = "2016",
month = "5",
day = "1",
doi = "10.1210/jc.2016-1104",
language = "English (US)",
volume = "101",
pages = "2226--2234",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Free 25-hydroxyvitamin D

T2 - Impact of vitamin D binding protein assays on racial-genotypic associations

AU - Osteoporotic Fractures in Men (MrOS) Research Group

AU - Nielson, Carrie

AU - Jones, Kerry S.

AU - Chun, Rene F.

AU - Jacobs, Jon M.

AU - Wang, Ying

AU - Hewison, Martin

AU - Adams, John S.

AU - Swanson, Christine M.

AU - Lee, Christine

AU - Vanderschueren, Dirk

AU - Pauwels, Steven

AU - Prentice, Ann

AU - Smith, Richard D.

AU - Shi, Tujin

AU - Gao, Yuqian

AU - Schepmoes, Athena A.

AU - Zmuda, Joseph M.

AU - Lapidus, Jodi

AU - Cauley, Jane A.

AU - Bouillon, Roger

AU - Schoenmakers, Inez

AU - Orwoll, Eric

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Context: Total 25-hydroxyvitamin D (25OHD) is a marker of vitamin D status and is lower in African Americans than in whites. Whether this difference holds for free 25OHOD (f25OHD) is unclear, considering reported genetic-racial differences in vitaminDbinding protein (DBP) used to calculate f25OHD. Objectives: Our objective was to assess racial-geographic differences in f25OHD and to understand inconsistencies in racial associations with DBP and calculated f25OHD. Design: This study used a cross-sectional design. Setting: The general community in the United States, United Kingdom, and The Gambia were included in this study. Participants: Men in Osteoporotic Fractures in Men and Medical Research Council studies (N = 1057) were included. Exposures: Total 25OHD concentration, race, and DBP (GC) genotype exposures were included. Outcome Measures: Directly measured f25OHD, DBP assessed by proteomics, monoclonal and polyclonal immunoassays, and calculated f25OHD were the outcome measures. Results: Total 25OHD correlated strongly with directly measured f25OHD (Spearman r = 0.84). Measured by monoclonal assay, mean DBP in African-ancestry subjects was approximately 50% lower than in whites, whereas DBP measured by polyclonal DBP antibodies or proteomic methods was not lower in African-ancestry. Calculated f25OHD (using polyclonal DBP assays) correlated strongly with directly measured f25OHD (r = 0.80-0.83). Free 25OHD, measured or calculated from polyclonal DBP assays, reflected total 25OHD concentration irrespective of race and was lower in African Americans than in US whites. Conclusions: Previously reported racial differences in DBP concentration are likely from monoclonal assay bias, as there was no racial difference in DBP concentration by other methods. This confirms the poor vitamin D status of many African-Americans and the utility of total 25OHD in assessing vitamin D in the general population.

AB - Context: Total 25-hydroxyvitamin D (25OHD) is a marker of vitamin D status and is lower in African Americans than in whites. Whether this difference holds for free 25OHOD (f25OHD) is unclear, considering reported genetic-racial differences in vitaminDbinding protein (DBP) used to calculate f25OHD. Objectives: Our objective was to assess racial-geographic differences in f25OHD and to understand inconsistencies in racial associations with DBP and calculated f25OHD. Design: This study used a cross-sectional design. Setting: The general community in the United States, United Kingdom, and The Gambia were included in this study. Participants: Men in Osteoporotic Fractures in Men and Medical Research Council studies (N = 1057) were included. Exposures: Total 25OHD concentration, race, and DBP (GC) genotype exposures were included. Outcome Measures: Directly measured f25OHD, DBP assessed by proteomics, monoclonal and polyclonal immunoassays, and calculated f25OHD were the outcome measures. Results: Total 25OHD correlated strongly with directly measured f25OHD (Spearman r = 0.84). Measured by monoclonal assay, mean DBP in African-ancestry subjects was approximately 50% lower than in whites, whereas DBP measured by polyclonal DBP antibodies or proteomic methods was not lower in African-ancestry. Calculated f25OHD (using polyclonal DBP assays) correlated strongly with directly measured f25OHD (r = 0.80-0.83). Free 25OHD, measured or calculated from polyclonal DBP assays, reflected total 25OHD concentration irrespective of race and was lower in African Americans than in US whites. Conclusions: Previously reported racial differences in DBP concentration are likely from monoclonal assay bias, as there was no racial difference in DBP concentration by other methods. This confirms the poor vitamin D status of many African-Americans and the utility of total 25OHD in assessing vitamin D in the general population.

UR - http://www.scopus.com/inward/record.url?scp=84969822892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969822892&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-1104

DO - 10.1210/jc.2016-1104

M3 - Article

VL - 101

SP - 2226

EP - 2234

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -